Fuqiang Hu

11.0k total citations · 1 hit paper
203 papers, 9.2k citations indexed

About

Fuqiang Hu is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Fuqiang Hu has authored 203 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 84 papers in Biomaterials and 58 papers in Pharmaceutical Science. Recurrent topics in Fuqiang Hu's work include Nanoparticle-Based Drug Delivery (82 papers), RNA Interference and Gene Delivery (53 papers) and Nanoplatforms for cancer theranostics (50 papers). Fuqiang Hu is often cited by papers focused on Nanoparticle-Based Drug Delivery (82 papers), RNA Interference and Gene Delivery (53 papers) and Nanoplatforms for cancer theranostics (50 papers). Fuqiang Hu collaborates with scholars based in China, Czechia and United States. Fuqiang Hu's co-authors include Hong Yuan, Yongzhong Du, Jian You, Su Zeng, Hong Yuan, Wei Wu, Tingting Meng, Yi Lü, Yi-Qing Ye and Saiping Jiang and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and ACS Nano.

In The Last Decade

Fuqiang Hu

199 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell membrane coated-nanoparticles for cancer immunotherapy

2022 159 citations Sufen Li, Shufen Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fuqiang Hu China	55	3.8k	3.6k	3.1k	2.5k	845	203	9.2k
Chul Soon Yong South Korea	56	3.1k 0.8×	2.6k 0.7×	3.6k 1.2×	2.5k 1.0×	707 0.8×	232	10.5k
Sanyog Jain India	56	3.2k 0.8×	3.3k 0.9×	3.7k 1.2×	1.8k 0.7×	567 0.7×	222	9.8k
Qineng Ping China	49	3.5k 0.9×	3.1k 0.9×	2.8k 0.9×	2.0k 0.8×	489 0.6×	213	8.7k
Guangxi Zhai China	53	2.8k 0.7×	2.7k 0.7×	3.0k 1.0×	1.8k 0.7×	964 1.1×	173	9.1k
Fatemeh Atyabi Iran	63	5.5k 1.5×	4.5k 1.3×	3.0k 1.0×	3.6k 1.5×	636 0.8×	331	13.2k
Hong Yuan China	53	3.0k 0.8×	3.0k 0.8×	1.8k 0.6×	2.2k 0.9×	474 0.6×	228	8.5k
Donatella Paolino Italy	53	2.5k 0.7×	3.0k 0.8×	3.2k 1.0×	1.5k 0.6×	1.2k 1.5×	188	9.0k
Yu Seok Youn South Korea	50	3.7k 1.0×	3.1k 0.9×	2.0k 0.7×	3.0k 1.2×	370 0.4×	239	9.1k
Christine Vauthier France	51	3.9k 1.0×	2.2k 0.6×	2.8k 0.9×	1.8k 0.7×	564 0.7×	143	8.4k
Han‐Gon Choi South Korea	65	4.3k 1.1×	3.8k 1.1×	6.0k 2.0×	3.7k 1.5×	914 1.1×	332	14.4k

Countries citing papers authored by Fuqiang Hu

Since Specialization

Citations

This map shows the geographic impact of Fuqiang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuqiang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuqiang Hu more than expected).

Fields of papers citing papers by Fuqiang Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuqiang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuqiang Hu. The network helps show where Fuqiang Hu may publish in the future.

Co-authorship network of co-authors of Fuqiang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Fuqiang Hu. A scholar is included among the top collaborators of Fuqiang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuqiang Hu. Fuqiang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Fuqiang, et al.. (2025). Oleic Acid-Shelled Solid Lipid Nanocomplexes for Enhanced Quercetin Delivery with Improved Antioxidant and Stability Properties. ACS Omega. 10(29). 32424–32432.

Wang, K., Yunxia Wang, Xiaomei Wu, et al.. (2024). Taprenepag restores maternal–fetal interface homeostasis for the treatment of neurodevelopmental disorders. Journal of Neuroinflammation. 21(1). 307–307.

Wang, Zixu, Fangying Yu, & Fuqiang Hu. (2024). Functional Chitosan and Its Derivative-Related Drug Delivery Systems for Nano-Therapy: Recent Advances. Pharmaceutics. 16(3). 337–337. 10 indexed citations

Wu, Xiaomei, et al.. (2024). Functionalized lipid nanoparticles modulate the blood-brain barrier and eliminate α-synuclein to repair dopamine neurons. Asian Journal of Pharmaceutical Sciences. 19(2). 100904–100904. 7 indexed citations

Li, Pei‐Rong, et al.. (2023). Polymer-Modified Lipid Nanoparticles with Microenvironment-Responsive Graded Release for Amplified Photodynamic Therapy Through Tumor Vascular Normalization. ACS Applied Nano Materials. 6(14). 13352–13362. 1 indexed citations

Yu, Fangying, Zixu Wang, Yun Zhu, et al.. (2023). Drug-independent NADPH-consuming micelles collaborate with ROS-generator for cascade ferroptosis amplification by impairing redox homeostasis. Materials Today Bio. 18. 100532–100532. 21 indexed citations

Wang, Kai, Wentao Zhou, Xiangyu Jin, et al.. (2023). Enhanced brain delivery of hypoxia-sensitive liposomes by hydroxyurea for rescue therapy of hyperacute ischemic stroke. Nanoscale. 15(27). 11625–11646. 13 indexed citations

Peng, Lijun, Fangying Yu, Tingting Meng, et al.. (2023). Glutathione Consumptive Dual-Sensitive Lipid-Composite Nanoparticles Induce Immunogenic Cell Death for Enhanced Breast Tumor Therapy. Molecular Pharmaceutics. 21(1). 113–125. 1 indexed citations

Tong, Yu, et al.. (2022). Combination of tumor vessel normalization and immune checkpoint blockade for breast cancer treatment via multifunctional nanocomplexes. Biomaterials Science. 10(15). 4140–4155. 6 indexed citations

10.

Liu, Yupeng, Fangying Yu, Suhuan Dai, et al.. (2021). All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis. Molecular Pharmaceutics. 18(11). 3966–3978. 28 indexed citations

11.

Zhou, Xueqing, et al.. (2020). Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment. Journal of Zhejiang University SCIENCE B. 21(3). 218–233. 10 indexed citations

12.

Yu, Fangying, Yun Zhu, Yupeng Liu, et al.. (2020). Poly-γ-glutamic acid derived nanopolyplexes for up-regulation of gamma-glutamyl transpeptidase to augment tumor active targeting and enhance synergistic antitumor therapy by regulating intracellular redox homeostasis. Biomaterials Science. 8(21). 5955–5968. 7 indexed citations

13.

Yang, Xiqin, Yu Tong, Xueqing Zhou, et al.. (2020). pH-Responsive Biomimetic Polymeric Micelles as Lymph Node-Targeting Vaccines for Enhanced Antitumor Immune Responses. Biomacromolecules. 21(7). 2818–2828. 60 indexed citations

14.

Tao, Shan, Shaoqing Chen, Wentao Zhou, et al.. (2020). A novel biocompatible, simvastatin-loaded, bone-targeting lipid nanocarrier for treating osteoporosis more effectively. RSC Advances. 10(35). 20445–20459. 22 indexed citations

15.

Miao, Jing, Xiqin Yang, Zhe Gao, et al.. (2019). Redox-responsive chitosan oligosaccharide-SS-Octadecylamine polymeric carrier for efficient anti-Hepatitis B Virus gene therapy. Carbohydrate Polymers. 212. 215–221. 32 indexed citations

16.

Han, Min, Qin Yu, Xuerong Liu, Fuqiang Hu, & Hong Yuan. (2018). Preparation and Characterization of a Novel Aqueous Dispersion for Enteric Coating of Pantoprazole Sodium Pellets. Acta Pharmaceutica. 68(4). 441–455. 12 indexed citations

17.

Tan, Yanan, Xiqin Yang, Suhuan Dai, et al.. (2018). In vivoprogramming of tumor mitochondria-specific doxorubicin delivery by a cationic glycolipid polymer for enhanced antitumor activity. Polymer Chemistry. 10(4). 512–525. 19 indexed citations

18.

Zhu, Yun, Tingting Meng, Yanan Tan, et al.. (2018). Negative Surface Shielded Polymeric Micelles with Colloidal Stability for Intracellular Endosomal/Lysosomal Escape. Molecular Pharmaceutics. 15(11). 5374–5386. 30 indexed citations

19.

Wang, Cheng, Xuerong Liu, Shaoqing Chen, et al.. (2018). Facile preparation of phospholipid–amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration. Chemical Communications. 54(93). 13080–13083. 51 indexed citations

20.

Hu, Fuqiang, et al.. (2015). Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways.. PubMed. 28(4). 649–57. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact